MED24
Basic information
Region (hg38): 17:40019097-40061215
Previous symbols: [ "THRAP4", "CRSP4" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MED24 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 3 | |||||
missense | 48 | 49 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 1 | |||||
Total | 0 | 0 | 48 | 1 | 4 |
Variants in MED24
This is a list of pathogenic ClinVar variants found in the MED24 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
17-40019536-G-A | not specified | Uncertain significance (Jan 23, 2024) | ||
17-40019587-G-A | not specified | Uncertain significance (Oct 12, 2021) | ||
17-40019613-G-A | Benign (Dec 26, 2018) | |||
17-40019641-G-A | not specified | Uncertain significance (Dec 11, 2023) | ||
17-40019778-T-C | Benign (Jun 10, 2018) | |||
17-40019797-C-T | not specified | Uncertain significance (Jul 12, 2023) | ||
17-40019819-C-T | not specified | Uncertain significance (Dec 28, 2022) | ||
17-40019856-T-G | not specified | Uncertain significance (Jun 13, 2024) | ||
17-40019873-T-C | not specified | Uncertain significance (Mar 15, 2024) | ||
17-40019891-G-A | not specified | Uncertain significance (Sep 25, 2023) | ||
17-40019895-G-A | not specified | Uncertain significance (May 23, 2023) | ||
17-40020297-G-A | not specified | Uncertain significance (Sep 01, 2021) | ||
17-40021963-G-A | not specified | Uncertain significance (Aug 17, 2022) | ||
17-40021979-C-T | not specified | Uncertain significance (May 24, 2023) | ||
17-40022004-C-T | not specified | Uncertain significance (Apr 13, 2022) | ||
17-40022014-G-A | not specified | Uncertain significance (Feb 27, 2023) | ||
17-40022407-C-T | not specified | Uncertain significance (Dec 02, 2022) | ||
17-40022434-G-A | not specified | Uncertain significance (Jul 20, 2022) | ||
17-40022663-G-A | not specified | Uncertain significance (May 16, 2023) | ||
17-40022688-T-C | not specified | Uncertain significance (May 31, 2023) | ||
17-40022693-G-A | not specified | Uncertain significance (Mar 07, 2024) | ||
17-40022757-G-T | not specified | Uncertain significance (Sep 14, 2022) | ||
17-40022789-C-T | Short stature | Likely pathogenic (Nov 18, 2001) | ||
17-40022790-G-A | not specified | Uncertain significance (Apr 22, 2022) | ||
17-40022808-G-C | not specified | Uncertain significance (May 04, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
MED24 | protein_coding | protein_coding | ENST00000394128 | 25 | 42119 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
3.32e-11 | 1.00 | 125637 | 0 | 111 | 125748 | 0.000441 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.63 | 414 | 594 | 0.697 | 0.0000356 | 6425 |
Missense in Polyphen | 106 | 172.13 | 0.61582 | 1995 | ||
Synonymous | 0.715 | 235 | 249 | 0.942 | 0.0000157 | 1964 |
Loss of Function | 3.31 | 26 | 51.7 | 0.503 | 0.00000255 | 576 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000873 | 0.000867 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000764 | 0.000761 |
Finnish | 0.000143 | 0.000139 |
European (Non-Finnish) | 0.000505 | 0.000492 |
Middle Eastern | 0.000764 | 0.000761 |
South Asian | 0.000338 | 0.000327 |
Other | 0.000996 | 0.000978 |
dbNSFP
Source:
- Function
- FUNCTION: Component of the Mediator complex, a coactivator involved in the regulated transcription of nearly all RNA polymerase II-dependent genes. Mediator functions as a bridge to convey information from gene-specific regulatory proteins to the basal RNA polymerase II transcription machinery. Mediator is recruited to promoters by direct interactions with regulatory proteins and serves as a scaffold for the assembly of a functional preinitiation complex with RNA polymerase II and the general transcription factors. {ECO:0000269|PubMed:12218053, ECO:0000269|PubMed:16595664}.;
- Pathway
- Thyroid hormone signaling pathway - Homo sapiens (human);Developmental Biology;Gene expression (Transcription);Generic Transcription Pathway;RNA Polymerase II Transcription;Transcriptional regulation of white adipocyte differentiation
(Consensus)
Recessive Scores
- pRec
- 0.132
Intolerance Scores
- loftool
- 0.902
- rvis_EVS
- -1.41
- rvis_percentile_EVS
- 4.13
Haploinsufficiency Scores
- pHI
- 0.216
- hipred
- Y
- hipred_score
- 0.648
- ghis
- 0.582
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.747
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Med24
- Phenotype
- embryo phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); growth/size/body region phenotype; muscle phenotype; cellular phenotype;
Zebrafish Information Network
- Gene name
- med24
- Affected structure
- mid intestine
- Phenotype tag
- abnormal
- Phenotype quality
- has fewer parts of type
Gene ontology
- Biological process
- transcription initiation from RNA polymerase II promoter;intracellular steroid hormone receptor signaling pathway;androgen receptor signaling pathway;positive regulation of transcription, DNA-templated
- Cellular component
- nucleus;nucleoplasm;mediator complex
- Molecular function
- transcription coregulator activity;protein binding;nuclear receptor transcription coactivator activity;signaling receptor activity;vitamin D receptor binding;thyroid hormone receptor binding